All Posts

Bayer Mentorship of Innovation Discovery Grant Winners Gets Underway

August 26, 2021

On August 25th Bayer and Mass General Brigham launched its Innovation Discovery Grant (IDG) mentorship program, kicking off a program that will connect Bayer mentors to the six 2021 IDG award recipients. At the launch, mentors…

Read More

Gene and Cell Therapies a Mass General Brigham System Wide Priority

July 23, 2021

In May the World Medical Innovation Forum featured panel discussions and content on cell and gene therapies across the sector. More than 20 hours of programming featured 150+ experts including clinical/scientific leaders, industry CEOs, venture investors,…

Read More

Innovator’s Commercialization Guide

July 23, 2021

Are you an innovator with ideas that you’d like to protect and commercialize? Do you imagine working with industry to commercialize an invention? Do you know who and how to contact the team at Mass General…

Read More

Venture, Grants and Funds Announcements

July 23, 2021

Mass General Brigham Ventures Current Stats $450 Million Capital Under Management 48 Portfolio Companies 15 Exits $148 Million Realized & Publicly Traded   Announcements Verve Therapeutics completes $306.7 million IPO We are pleased to announce that…

Read More

New Initiative Seeks to Enhance Diversity, Equity and Inclusion in the Innovation Process

July 23, 2021

The Nobel prize-winning American chemist Linus Pauling once said, “If you want to have good ideas, you must have many ideas.” Generating more ideas for new drugs, devices and therapeutics; increasing the diversity of researchers participating…

Read More

Rebuilding the Brain in Parkinson’s Disease

June 30, 2021

Gene and cell therapy at a crossroads After glimpsing the promise of gene and cell therapy, Mass General Brigham researchers are now enhancing the technology to drive new treatments for rare and common diseases Replacing defective…

Read More

‘Moving the Needle’ for Glioblastoma

June 30, 2021

Gene and cell therapy at a crossroads After glimpsing the promise of gene and cell therapy, Mass General Brigham researchers are now enhancing the technology to drive new treatments for rare and common diseases Replacing defective…

Read More

Toward Gene Therapies for Hearing Loss

June 30, 2021

Gene and cell therapy at a crossroads After glimpsing the promise of gene and cell therapy, Mass General Brigham researchers are now enhancing the technology to drive new treatments for rare and common diseases Replacing defective…

Read More

Driven to Solve Devastating Rare Diseases

June 30, 2021

Gene and cell therapy at a crossroads After glimpsing the promise of gene and cell therapy, Mass General Brigham researchers are now enhancing the technology to drive new treatments for rare and common diseases Replacing defective…

Read More

2021 WMIF Panels: Illustrated

June 5, 2021

For each 2021 World Medical Innovation panel over the course of three days, visual drawings were made to encapsulate what was discussed in an illustrative way. To view, download them all here.

Read More

2021 Disruptive Dozen

June 2, 2021

The three-day forum concluded with the introduction of the Disruptive Dozen—12 new technologies identified by senior leaders from Mass General Brigham as having the chance to significantly improve healthcare in the next two years. #12 |…

Read More

2021 Innovation Discovery Grants (IDG) Awarded

June 2, 2021

Thursday afternoon highlights also included the awarding of six Innovation Discovery Grants (IDG) to Mass General Brigham investigators working on gene and cell therapy (GCT) advancements. Each award winner will receive $100,000 toward ongoing development and…

Read More

2021 World Medical Innovation Forum | Day 3 Recap

June 2, 2021

Day 3 of the World Medical Innovation Forum codified the challenges of bringing new gene and cell therapies to market—shared across treatment strategies, delivery systems and disease areas. Priority needs included more reliable and repeatable manufacturing…

Read More

2021 World Medical Innovation Forum | Day 2 Recap

June 2, 2021

Day Two of the World Medical Innovation Forum took a deeper dive into the potential of GCT therapeutics to treat different diseases—from ultra-rare genetic disorders to highly prevalent chronic diseases such as diabetes. Discussions touched on…

Read More

2021 World Medical Innovation Forum | Day 1 Recap

June 2, 2021

“Now that the first crop of gene and cell therapy (GCT) treatments have reached the market, where should the field head next?” “How can patients, clinicians, regulators, payers and members of industry work collaboratively to expand…

Read More

2021 Innovation Discovery Grants Awarded

May 20, 2021

Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring. Read More: https://www.massgeneralbrigham.org/newsroom/press-releases/innovation-discovery-grants-awarded-mass-general-brigham-scientific-0 Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD,…

Read More

GCT Breakthroughs Focus of World Forum May 19-21

May 19, 2021

Gene and cell therapy (GCT), a transformative approach to develop treatments, and, potentially, cures for congenital and other diseases, is the focus of this year’s World Medical Innovation Forum May 19-21. Read more: https://www.massgeneralbrigham.org/newsroom/press-releases/gene-and-cell-therapy-breakthroughs-focus-world-medical-innovation-forum

Read More

Lessening the Burden of Type 1 Diabetes with Innovative Cell Therapies

May 6, 2021

By: Manasi Sinha Jaiman, M.D., M.P.H., Vice President, Clinical Development Imagine an 18-year-old walking into my office. She is looking forward to graduation.  Feeling the thrill of receiving that college acceptance letter.  Planning gatherings with friends…

Read More